Join Growin Stock Community!

懷特4108.TW Overview

TW StockBiotech. & Medical
(No presentation for 4108)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

懷特（4108）Overall Performance

懷特（4108）AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

懷特（4108） PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

懷特（4108）Key Information

懷特（4108）Profile

PhytoHealth Corporation researches and develops, manufactures, and sells pharmaceutical drugs, cosmetics, Class B medicines, and supplementary foods and other related products. Its products include PG2 Lyophilized injection for the treatment of cancer related fatigue; EnerCharge, which is used in enhancing physical strength, maintaining good spirits, and enhancing health maintenance activities; ReyeasCleanse health food capsules; and EnerCharge, an energy drink. The company also offers precision medical equipment and instrument; medical diagnosis software; and computer-aided diagnosis system authorization services. PhytoHealth Corporation was incorporated in 1998 and is based in Taipei, Taiwan.

懷特（4108）FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-0.29
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
20.29
PB Ratio
1.19
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
30.68%
Net Margin
-43.25%
Revenue Growth (YoY)
-13.76%
Profit Growth (YoY)
-34.12%
3-Year Revenue Growth
-0.65%
3-Year Profit Growth
-23.28%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-0.29
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
20.29
PB Ratio
1.19
Price-to-FCF
-
Gross Margin
30.68%
Net Margin
-43.25%
Revenue Growth (YoY)
-13.76%
Profit Growth (YoY)
-34.12%
3-Year Revenue Growth
-0.65%
3-Year Profit Growth
-23.28%
4108.TW logo

4108

懷特

13.75D

-1.09%

(-0.01)

  • When is 4108's latest earnings report released?

    The most recent financial report for 懷特 (4108) covers the period of 2025Q4 and was published on 2025/12/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 4108's short-term business performance and financial health. For the latest updates on 4108's earnings releases, visit this page regularly.

  • What is the operating profit of 4108?

    According to the latest financial report, 懷特 (4108) reported an Operating Profit of -42.14M with an Operating Margin of -127.15% this period, representing a growth of 7.62% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is 4108's revenue growth?

    In the latest financial report, 懷特 (4108) announced revenue of 33.14M, with a Year-Over-Year growth rate of 0.11%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much cash does 4108 have?

    At the end of the period, 懷特 (4108) held Total Cash and Cash Equivalents of 86.8M, accounting for 0.04 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does 4108 go with three margins increasing?

    In the latest report, 懷特 (4108) did not achieve the “three margins increasing” benchmark, with a gross margin of 18.27%%, operating margin of -127.15%%, and net margin of -92.04%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 4108's profit trajectory and future growth potential.

  • Is 4108's EPS continuing to grow?

    According to the past four quarterly reports, 懷特 (4108)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at -0.09. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of 4108?

    懷特 (4108)'s Free Cash Flow (FCF) for the period is 101.85M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 172.46% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.